What's Keeping Korea From Becoming A Digital Healthcare Power?
While digital healthcare start-ups are increasingly being established in South Korea, strict regulations and a limited market environment are keeping them from adopting innovative ideas and technologies to rapidly catch up with global competitors. A recent report on digital healthcare suggests what issues need to be resolved to improve the situation.
You may also be interested in...
Application of artificial intelligence to new drug development in South Korea, which has been lagging in this area, is poised to accelerate as the country moves to support and encourage the technology.
HanAll and Daewoong remain upbeat on dry eye candidate HL036 and are gearing up for a second Phase III US study despite the first missing its primary endpoint in just-released top-line results.
Among the Korean firms presenting at J.P. Morgan, Hanmi laid out its strategy for obesity and other core pipeline assets, Celltrion focused on its expanding biosimilar pipeline and China plans and LG Chem unveiled new R&D progress.